TBXT and neoplasm: Very importantly, JCPyV early protein, T-Antigen is robustly expressed in all the tumors, but interestingly, it is present in approximately 65–70% of neoplastic cells, while a small subpopulation of these tumor cells remains negative (Figure 4B).